• P. Debyelaan 25

    6229 HX Maastricht

    Netherlands

Profiles

No photo of Roy Kruitwagen

Roy Kruitwagen

Person: Paid Staff - Academic Staff, Paid Staff - azM-employee, Unpaid Staff - Academic Staff AZM

20012019

Research Output

Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial

de Boer, S. M., Powell, M. E., Mileshkin, L., Katsaros, D., Bessette, P., Haie-Meder, C., Ottevanger, P. B., Ledermann, J. A., Khaw, P., D'Amico, R., Fyles, A., Baron, M-H., Jurgenliemk-Schulz, I. M., Kitchener, H. C., Nijman, H. W., Wilson, G., Brooks, S., Gribaudo, S., Provencher, D., Hanzen, C. & 11 others, Kruitwagen, R. F., Smit, V. T. H. B. M., Singh, N., Do, V., Lissoni, A., Nout, R. A., Feeney, A., Verhoeven-Adema, K. W., Putter, H., Creutzberg, C. L. & PORTEC Study Grp, Sep 2019, In : Lancet oncology. 20, 9, p. 1273-1285 13 p.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

Borderline tumours of the ovary: Common practice in the Netherlands

De Decker, K., ter Brugg, H. G., Bart, J., Kruitwagen, R. F. P. M., Nijman, H. W. & Kruse, A-J., Feb 2019, In : Gynecologic Oncology Case Reports. 27, p. 25-30 6 p.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access